Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessResearch article

Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease

Gemma Casadesus1 email, Mark A Smith2 email, Samar Basu3 email, Jing Hua2 email, Dae E Capobianco2 email, Sandra L Siedlak2 email, Xiongwei Zhu2 email and George Perry2,4 email

Department of Neuroscience, Case Western Reserve University, Cleveland, Ohio, USA

Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA

Faculty of Medicine, Uppsala University, Uppsala, Sweden

College of Sciences, University of Texas at San Antonio, Texas, USA

author email corresponding author email

Molecular Neurodegeneration 2007, 2:2doi:10.1186/1750-1326-2-2

Published: 22 January 2007

Abstract

Background

Inflammation and oxidative stress are both involved in the pathogenesis of Alzheimer disease and have been shown to be reciprocally linked. One group of molecules that have been directly associated with inflammation and the production of free radicals are the prostaglandin 13,14-dihydro 15-keto PGF2α and the isoprostane 8-iso-PGF2α.

Results

To further delineate the role of inflammatory and oxidative parameters in Alzheimer disease, in this study we evaluated the amount and localization of 13,14-dihydro 15-keto PGF2α and 8-iso-PGF2α in hippocampal post mortem tissue samples from age-matched Alzheimer disease and control patients. Our results demonstrate increased levels of 13,14-dihydro 15-keto PGF2α and 8-iso-PGF2α in the hippocampal pyramidal neurons of Alzheimer disease patients when compared to control patients.

Conclusion

These data not only support the shared mechanistic involvement of free radical damage and inflammation in Alzheimer disease, but also indicate that multiple pathogenic "hits" are likely necessary for both the development and propagation of Alzheimer disease.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.